SIP
IMPV

Stoneridge Investment Partners’s Imperva, Inc. IMPV Stock Holding History

Stoneridge Investment Partners’s Portfolio IMPV Stock Details IMPV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,554
Closed -$310K – 342
2017
Q1 		$310K Sell
7,554
-3,740
-33% -$156K 0.04% 250
2016
Q4 		$434K Buy
+11,294
New +$459K 0.06% 230

Other funds holding IMPV

EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Stoneridge Investment Partners's IMPV Position: Q2 2017 in Review

Stoneridge Investment Partners sold out of Imperva, Inc. (IMPV) in Q2 2017, closing a stake of 7,554 shares — an estimated $310K sold.

Stoneridge Investment Partners first reported a position in IMPV in Q4 2016 and held it in 2 quarters. The position peaked at $434K in Q4 2016. 181 funds tracked by Wall St. Rank hold IMPV as of Q2 2017.

  • Stoneridge Investment Partners reported no remaining Imperva, Inc. position as of Q2 2017 after selling out during the quarter.
  • Stoneridge Investment Partners sold 7,554 Imperva, Inc. shares in Q2 2017, an estimated $310K.
  • Stoneridge Investment Partners first reported a position in Imperva, Inc. in Q4 2016 and held it in 2 quarters.
  • Stoneridge Investment Partners's Imperva, Inc. position peaked at $434K in Q4 2016.
  • 181 funds tracked by Wall St. Rank held Imperva, Inc. as of Q2 2017.

Based on Stoneridge Investment Partners's 13F filing for Q2 2017, filed 1 Aug 2017.